AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Current Liabilities

Annual Current Liabilities:

$28.41M-$53.64M(-65.38%)
December 31, 2024

Summary

  • As of today, AMLX annual current liabilities is $28.41 million, with the most recent change of -$53.64 million (-65.38%) on December 31, 2024.
  • During the last 3 years, AMLX annual current liabilities has risen by +$11.01 million (+63.29%).
  • AMLX annual current liabilities is now -65.38% below its all-time high of $82.04 million, reached on December 31, 2023.

Performance

AMLX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Quarterly Current Liabilities:

$21.42M+$3.49M(+19.47%)
June 1, 2025

Summary

  • As of today, AMLX quarterly current liabilities is $21.42 million, with the most recent change of +$3.49 million (+19.47%) on June 1, 2025.
  • Over the past year, AMLX quarterly current liabilities has dropped by -$48.66 million (-69.43%).
  • AMLX quarterly current liabilities is now -76.62% below its all-time high of $91.64 million, reached on March 31, 2024.

Performance

AMLX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

AMLX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-65.4%-69.4%
3Y3 Years+63.3%-21.1%
5Y5 Years+527.2%+192.4%

AMLX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-65.4%+63.3%-76.6%+19.5%
5Y5-Year-65.4%+527.2%-76.6%+192.4%
All-TimeAll-Time-65.4%+527.2%-76.6%+192.4%

AMLX Current Liabilities History

DateAnnualQuarterly
Jun 2025
-
$21.42M(+19.5%)
Mar 2025
-
$17.93M(-36.9%)
Dec 2024
$28.41M(-65.4%)
$28.41M(-47.3%)
Sep 2024
-
$53.91M(-23.1%)
Jun 2024
-
$70.08M(-23.5%)
Mar 2024
-
$91.64M(+11.7%)
Dec 2023
$82.04M
$82.04M(+79.8%)
Sep 2023
-
$45.62M(-28.8%)
DateAnnualQuarterly
Jun 2023
-
$64.08M(+24.2%)
Mar 2023
-
$51.62M(+10.7%)
Dec 2022
$46.61M(+167.9%)
$46.61M(+42.8%)
Sep 2022
-
$32.65M(+20.2%)
Jun 2022
-
$27.16M(-2.0%)
Mar 2022
-
$27.71M(+59.3%)
Dec 2021
$17.40M(+137.5%)
$17.40M(+137.5%)
Dec 2020
$7.33M(+61.8%)
$7.33M
Dec 2019
$4.53M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual current liabilities?
  • What is the all-time high annual current liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual current liabilities year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly current liabilities?
  • What is the all-time high quarterly current liabilities for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual current liabilities?

The current annual current liabilities of AMLX is $28.41M

What is the all-time high annual current liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual current liabilities is $82.04M

What is Amylyx Pharmaceuticals, Inc. annual current liabilities year-on-year change?

Over the past year, AMLX annual current liabilities has changed by -$53.64M (-65.38%)

What is Amylyx Pharmaceuticals, Inc. quarterly current liabilities?

The current quarterly current liabilities of AMLX is $21.42M

What is the all-time high quarterly current liabilities for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly current liabilities is $91.64M

What is Amylyx Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?

Over the past year, AMLX quarterly current liabilities has changed by -$48.66M (-69.43%)
On this page